BioCorRx raises $300K via common stock and warrant sale to accredited investor

BioCorRx Inc.

Sold 174,409 shares of common stock at $1.72/share for total proceeds of $300,000.
Issued a warrant to purchase 174,409 shares at $4.00/share, exercisable for 3 years.
Securities issued in a private placement exempt from registration under Securities Act.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

BioCorRx Inc. entered into Subscription Agreement with an accredited investor valued at $300,000 (effective 2023-04-04).

Action: entry
Agreement: equity purchase
Counterparty: an accredited investor
Value: $300,000
Effective: 2023-04-04

Exact text from the filing

On April 4, 2023, BioCorRx Inc., a Nevada corporation (the “Company”), entered into a Subscription Agreement (the “Subscription Agreement”) with an accredited investor (the “Investor”).

View on SEC.gov

Browse all material agreements →

BioCorRx Inc. filing history →

Source: SEC EDGAR

accession 0001477932-23-002411

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.